The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Thu, 03rd Sep 2020 16:06

Friday 4 September 
Berkeley Group Holdings PLCAGM
IDE Group Holdings PLCAGM
Amino Technologies PLCGM re dividend resolution
Allianz Technology Trust PLCGM re share issue
Halma PLCAGM
Monday 7 September 
International Consolidated Airlines Group SAAGM
Spitfire Oil LtdGM re dissolving company
Tuesday 8 September 
Hipgnosis Songs Fund LtdAGM
XPS Pensions Group PLCAGM
Oxford Instruments PLCAGM
Ashtead Group PLCAGM
Civitas Social Housing plcAGM
DS Smith PLCAGM
Royal Mail PLCAGM
NB Global Floating Rate Income Fund LtdEGM re changes to investment policy, exit offer
Equatorial Palm Oil PLCGM re share placing
Wednesday 9 September 
PetroTal CorpGM re share consolidation
Mobeus Income & Growth 2 VCT PLCAGM
Bermele PLCAGM
AEW UK REIT PLCAGM
Chelverton UK Dividend Trust PLCAGM
Walker Crips Group PLCAGM
PV Crystalox Solar PLCGM re tender offer
Thursday 10 September 
Dixons Carphone PlcAGM
Montanaro European Smaller Cos Trust PLCAGM
NB Private Equity Partners LtdAGM
Atlantis Japan Growth Fund LtdAGM
ReNeuron Group PLCAGM
Tertiary Minerals PLCGM re buyback of deferred shares
Beowulf Mining PLCAGM
British Smaller Companies VCT PLCAGM
U & I Group PlcAGM
Fuller Smith & Turner PLCAGM
Victoria PLCAGM
Speedy Hire PLCAGM
Brown (N) Group PLCAGM
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Oct 2021 19:06

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

TRADING UPDATES: Yellow Cake fundraises; Mercia Asset invests

Read more
26 Oct 2021 14:02

ReNeuron enters cancer therapy collaboration with UCL

(Sharecast News) - Cell-based therapeutic specialist ReNeuron has entered a collaboration agreement with University College London (UCL), it announced on Tuesday, to conduct research into the generation of immune cells from induced pluripotent stem cells (iPSCs), for anti-cancer cell therapies.

Read more
21 Oct 2021 16:40

Director dealings: Reneuron Group non-executive makes share purchase

(Sharecast News) - Reneuron Group revealed on Thursday that non-executive director Barbara Staehelin had acquired 43,000 ordinary shares in the AIM-listed cell-based therapeutics developer.

Read more
21 Oct 2021 14:07

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

DIRECTOR DEALINGS: Inspiration Healthcare exec sells 135,000 shares

Read more
18 Oct 2021 15:12

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

TRADING UPDATES: Mind Gym revenue recovers; Dispersion buys Accru

Read more
18 Oct 2021 09:14

ReNeuron treats first Oxford patient as part of expanded study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group said on Monday that the first UK subject had been treated at the Oxford Eye Hospital as part of its phase 2a clinical evaluations for the treatment of retinitis pigmentosa (RP) - an inherited, degenerative eye disease.

Read more
11 Oct 2021 11:51

ReNeuron upbeat on positive data from Spain collaboration

(Sharecast News) - Exosome therapeutics developer ReNeuron announced positive data on Monday that it said provided "clear preclinical proof-of-concept" that its novel exosome drug delivery technology could effectively deliver therapeutic proteins to the specific region of the brain affected by several neurological diseases.

Read more
11 Oct 2021 11:05

IN BRIEF: ReNeuron gets positive results from exosome drug data

IN BRIEF: ReNeuron gets positive results from exosome drug data

Read more
11 Oct 2021 10:59

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

Read more
1 Oct 2021 11:15

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Read more
1 Oct 2021 10:33

ReNeuron gets approval to restart RP clinical study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on its phase 2a clinical evaluations for the treatment of the inherited, degenerative eye disease retinitis pigmentosa on Friday, confirming that it had received regulatory approval to restart the study in all geographies.

Read more
9 Sep 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
6 Aug 2021 10:55

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

ReNeuron taps Oxford Biomedica executive Catherine Isted as CFO

Read more
14 Jul 2021 15:15

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

IN BRIEF: ReNeuron hires Swiss exec as senior independent director

Read more
8 Jul 2021 11:38

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

TRADING UPDATES: Jet2 swings to loss; Hyve Group sees busiest quarter

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.